[O7] Developmental disorderAutism spectrum disorder

Thu. May 31, 2018 10:10 AM - 11:20 AM Room 8 (1F 103)

Chair:Takashi HAYASHI MD PhD(Nishikawa Clinic Department of developmental medicine), FURUSHO Junichi, Professor, MD.(College of Education, Psychology and Human Studies, Department of Education,Aoyamagakuin University.)

+Add all to schedule

[O-035] Tympanic deep body temperature as a biomarker of autism spectrum disorders；The second report

Tomohiro Nakayama^1,2, HARUKA OOGURO¹, NAOKO NAKAYAMA², JUNKO NAKAYAMA¹, NOBUAKI IWASAKI¹ (1.Department of Pediatrics, Ibaraki Prefectural University of Health Sciences Hospital, Ibaraki, Japan, 2.Department of Pediatrics, Matsudo Clinic, Chiba, Japan)

[O-036] Cohort Study for early detection of ASD: Trajectory of Prefarentioal looking in 2—3 years—olds

Tatsuya Koeda¹, Sawako Ohba², Yoshihiro Maegaki³ (1.Department of Psychosocial Medicine, National Center for Child Health and Development, Tokyo, Japan, 2.Graduate School of Medicine, Tottori University, Yonago, Japan, 3.Division of Child Neurology, Faculty of Medicine, Tottori University, Yonago, Japan)

[O-037] Evaluation of expression recognition function using near infrared spectroscopy

Kenji Mori¹, AYA GOJI², TATSUO MORI², YOSHIHIRO TODA², HIROMICHI ITO², MASAHITO MIYAZAKI², SHOJI KAGAMI² (1.Department of Child Health & Nursing, Tokushima University Graduate School, Tokushima, Japan, 2.Department of Pediatrics, Tokushima University Graduate School, Tokushima, Japan)

[O-038] Preliminary study of oxidative stress in children with autism spectrum disorders

Toshiaki Hashimoto¹, MASAHITO MORIMOTO², YOSHIMI TSUDA¹, TAISUKE KITAIKA³, SHOJIRO KYOTANI³ (1.Department of pediatrics, Japanese Red Cross Tokushima Hinomine Rehabilitation Center for People with Disabilities, Tokushima, Japan, 2.Department of pharmacy, Japanese Red Cross Tokushima Hinomine Rehabilitation Center for People with Disabilities, Tokushima, Japan, 3.Tokushima Bunri University, Graduate School of Pharmaceutical Sciences, Tokushima, Japan)

[O-039] Early weight gain effects of second—generation antipsychotic treatment in autism spectrum disorder

Yuko Hayashi¹, AKEMI TOROBU², KAYO KAMOSHITA² (1.Department of Pediatirics ,Medical Center,, Faculty of Health and Welfare, Prefectural University of Hiroshima, Mihara,Japan, 2.Department of Nursing, Faculty of Health and Welfare, Prefectural University of Hiroshima, Mihara,Japan)

[O-040] Assessment of anterior cingulate cortex and left cerebellum in autism spectrum disorder using 1H—MRS

Hiromichi Ito^1,2, KENJI MORI³, MASAFUMI HARADA⁴, SONOKA HISAOKA⁴, YOSHIHIRO TODA², TATSUO MORI², AYA GOJI², YOKO TAKAMI², MASAHITO MIYAZAKI², SHOJI KAGAMI² (1.Department of Special Needs Education, Graduate School of Education, Naruto University of Education, Tokushima, Japan, 2.Department of Pediatrics, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima City, Tokushima 770-8503, Japan., 3.Department of Child Health & Nursing, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima City, Tokushima 770-8503, Japan., 4.Department of Radiology, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima City, Tokushima 770-8503, Japan.)

[O-041] In utero exposure to valproic acid throughout pregnancy cause autistic phenotype in offspring mice

Takayuki Mitsuhashi¹, Satoko Hattori², Kimino Fujimura¹, Shinsuke Shibata³, Tsuyoshi Miyakawa², Takao Takahashi¹ (1.Pediatrics, Keio University School of Medicine, Tokyo, Japan, 2.Division of Systems Medical Science, Institute for Comprehensive Medical Science, Fujita Health University, Aichi, Japan, 3.Electron Microscope Laboratory, Keio University School of Medicine, Tokyo, Japan)